Login / Signup

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer.

Daniel J GeorgeKrishnan RamaswamyAhong HuangDavid RussellJack MardekianNeil M SchultzNora JanjanStephen J Freedland
Published in: Prostate cancer and prostatic diseases (2021)
In the VHA, black men with chemotherapy-naïve mCRPC initiating NHT may have better outcomes than similarly treated white men.
Keyphrases
  • middle aged
  • prostate cancer
  • locally advanced
  • squamous cell carcinoma
  • hiv infected
  • adipose tissue
  • skeletal muscle
  • insulin resistance
  • chemotherapy induced
  • weight loss